Chao-min Huang

Pingtung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Soil to tobacco component transfer factors for natural radionuclides 40K, 226Ra, and 232Th and the risk assessment of tobacco leaf in smoking.

Soil to tobacco component transfer factors for natural radionuclides 40K, 226Ra, and 232Th and the risk assessment of tobacco leaf in smoking.

Journal: Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering
Published: July 28, 2022

ASSESSMENT OF DOSES FROM INGESTION OF RADIONUCLIDES 40 K, 137CS, 226RA AND 232TH IN EDIBLE COMMERCIAL MUSHROOMS FROM TAIWAN.

ASSESSMENT OF DOSES FROM INGESTION OF RADIONUCLIDES 40 K, 137CS, 226RA AND 232TH IN EDIBLE COMMERCIAL MUSHROOMS FROM TAIWAN.

Journal: Radiation protection dosimetry
Published: March 10, 2022

Activity concentrations and bioconcentration factors (BCFs) of natural radionuclides (40 K, 226Ra, and 232Th) from cultivated substrates to mushrooms.

Activity concentrations and bioconcentration factors (BCFs) of natural radionuclides (40 K, 226Ra, and 232Th) from cultivated substrates to mushrooms.

Journal: Environmental science and pollution research international
Published: November 16, 2021

Biomechanical analysis of subcondylar fracture fixation using miniplates at different positions and of different lengths.

Biomechanical analysis of subcondylar fracture fixation using miniplates at different positions and of different lengths.

Journal: BMC oral health
Published: July 10, 2021

Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agents.

Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agents.

Journal: Medicine
Published: November 18, 2017

Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study.

Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: June 07, 2017

Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.

Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.

Journal: PloS one
Published: January 10, 2017

MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirin.

MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirin.

Journal: Scientific reports
Published: April 19, 2016

Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus.

Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus.

Journal: International journal of cancer
Published: April 26, 2015

Significance of vitamin d receptor gene polymorphisms for risk of hepatocellular carcinoma in chronic hepatitis C.

Significance of vitamin d receptor gene polymorphisms for risk of hepatocellular carcinoma in chronic hepatitis C.

Journal: Translational oncology
Published: March 18, 2014

A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.

A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: January 04, 2014

Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.

Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.

Journal: Antiviral therapy
Published: October 26, 2011
Showing 1-12 of 12

Last Updated: 09/26/2026